NIH-funded research P30 center grant

A core facility providing advanced genomic services for targeted therapeutics.

Official title: Functional Genomics Core

Funded at University of South Carolina at Columbia · NIH-10936195 · Data updated 2026-11-12

The Functional Genomics Core at the University of South Carolina helps scientists learn and use advanced techniques to study genes, which could lead to new treatments for patients in the future.

Quick facts

Grant typeP30 center grant
Study typeNIH-funded research
Funding institutionUniversity of South Carolina at Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startJuly 15, 2024
Project endMay 31, 2029
Funding year2024
Award (this year)$227,399
NIH project number1P30GM154632-01
Project IDNIH-10936195 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research are individuals with conditions that could be addressed through targeted genomic therapies.

Less likely to help

Patients with conditions that are not related to genomic or targeted therapeutic approaches may not receive any benefit from this research.

What this research studies

The Functional Genomics Core (FGC) at the University of South Carolina offers cutting-edge genomic, transcriptomic, and epigenomic services to researchers. This facility supports investigators by providing training in Next Generation sequencing and cell line modification techniques. By collaborating with various laboratories, the FGC aims to enhance research capabilities in targeted therapeutics. Patients may benefit indirectly as the research conducted here could lead to new treatments and therapies based on genomic insights.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective targeted therapies for various diseases.

How similar studies have gone: Previous research in functional genomics has shown promise in advancing targeted therapies, indicating that this approach is both relevant and potentially impactful.

Where this research is happening

  • University of South Carolina at Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Shtutman, Michael — University of South Carolina at Columbia
  • Study coordinator: Shtutman, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.